Serial Number
97514039
Owner
Clementia Pharmaceuticals Inc.Attorney
Makiko CofflandFiling Date
Jul 21, 2022
KYTOMY Trademark
Serial Number: 97514039
Trademark Classes
Owner Contact Info
1155 Rue Metcalfe, Suite 1500
Montreal, Quebec H3B2V6 , CA
Entity Type: 03
Legal Representation
Correspondence Address
Makiko Coffland CHRISTENSEN O'CONNOR JOHNSON KINDNESS
1201 THIRD AVENUE, SUITE 3600
SEATTLE, WA 98101
United States
Trademark Details
Filing Date
July 21, 2022
Registration Date
Not Registered
Published for Opposition
September 22, 2026
Goods & Services
Pharmaceutical preparations for use in the prevention and the treatment of cancer, rare autoimmune diseases and disorders, autoimmune diseases and disorders, liver diseases, biliary diseases, namely bile ducts and gallbladder, metabolic diseases, namely diabetes, hypoglycemia, gout, arthritis, muscular dystrophy and anemia, inflammatory diseases namely, inflammatory bowel diseases, enteric diseases and inflammatory connective tissue diseases, urological diseases, disorders and diseases of the reproductive system namely, sexual reproduction and fertility, puberty diseases or disorders, namely, precocious puberty, gynecological disorders namely, menstrual irregularities and menopause-related diseases and symptoms, namely, anemia, fertility, acromegalia and tumors, hormonal disorders; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the endocrine system, namely, glucagonoma, growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management, inflammatory connective tissue diseases, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, namely, epilepsy, multiple sclerosis, headache, brain tumors, Parkinson's disease, Huntington's disease, Alzheimer's disease, dementia; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome; pharmaceutical preparations and substances for the prevention and treatment of pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin namely, acne, rosacea, dermatitis, psoriasis, vitiligo, hives, alopecia areata, Lupus; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutinin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified component of the toxin haemagglutinin complex for skin care and the treatment of neurological disorders
